Salute e Benessere

Information on the Total Number of Voting Rights (Denominator) following…

Regulated Information - Denominator Atlas Special Opportunities, LLChas converted 6convertible bonds in Oxurion resulting in a EUR 150 ,000capital increase. This is part of Atlas Special Opportunities, LLC's EUR 20 million Capital Commitment1 that will allow Oxurion to focus on progressing its novel and differentiated back of the eye drug candidate targeting potential market opportunities of over USD 5billion.Leuven, BELGIUM ,Boston, MA, US –...
Nasdaq GlobeNewswire
22/06/2023

Press Release: Availability of the Q2 2023 Memorandum for modelling purposes

Availability of the Q2 2023 Memorandum for modelling purposesParis, France – June 22, 2023. Sanofi announced today that its Q2 2023 Memorandum for modelling purposes is available on the "Investors" page of the company's website: https://www.sanofi.com/en/investors/financial-results-and-events/financial-results/q2-results-2023 As for each quarter, Sanofi prepared this document to assist in the financial modelling of the Group's quarterly results. This document includes a reminder...
Nasdaq GlobeNewswire
22/06/2023

Hyloris announces enrolment of first patient in a 4-arm clinical trial of…

Potential first-line treatment for interstitial cystitis/bladder pain syndrome (IC/BPS)Global opportunity with a patient population of at least 6 million in the U.S. alone 1 Liège, Belgium – 22 June 2023–7AM CET – Non-regulated information - Hyloris Pharmaceuticals SA (Euronext Brussels: HYL),a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, today announces that the first patient has been enrolled in a...
Nasdaq GlobeNewswire
22/06/2023

Valneva Supervisory Board Recommends Transition from a Two-Tier Governance Model…

Saint-Herblain (France), June 22 , 2023–ValnevaSE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that its Supervisory Board has recommended a change of governance model.The Company's Supervisory Board members voted in favor of recommending to the shareholders to transition from the Company's current two-tier governance model, which includes a Supervisory Board and a Management Board, to a one-tier model led by a Board of...
Nasdaq GlobeNewswire
22/06/2023

Polyplastics Announces Commercial Availability of DURACON (R) POM PM Series for…

In the medical device marketplace, manufacturers and end users demand high-quality materials from reliable suppliers. Polyplastics has served the medical and healthcare field for decades with its high-purity TOPAS (R) COC (cyclic olefin copolymer). As the world's leading POM manufacturer, Polyplastics now adds the PM Series to its medical grade portfolio and plans to expand material supply to the medical and healthcare market. In the medical device marketplace, manufacturers and end users...
PR Newswire
22/06/2023

Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance…

Proceeds will be used to advance the lead program, a click-cleavable ADC targeting TAG72, into the clinic, and expand the pipeline Proceeds will be used to advance the lead program, a click-cleavable ADC targeting TAG72, into the clinic, and expand the pipeline Chris Martin, DPhil, former CEO of ADC Therapeutics, appointed Board Chair andJay Feingold, M.D., Ph.D., former Chief Medical Officer of Pyxis Oncology and ADC Therapeutics, appointed CMO NIJMEGEN,Netherlandsand...
PR Newswire
22/06/2023

European Wellness Signs a Multi-Million MOU for MF3 of Switzerland Supplements &…

Witnessed by The Honourable Dato' Seri Anwar bin Ibrahim, the 10th Prime Minister of Malaysia, the MOU was signed by EW Group Chairman, Prof Dato' Sri Dr Mike Chan and SDFT Co. Director, Zhang De Ping. Witnessed by The Honourable Dato'Seri Anwar bin Ibrahim, the 10 thPrime Minister ofMalaysia, the MOU was signed by EW Group Chairman, Prof Dato' Sri DrMike Chanand SDFT Co. Director,Zhang De Ping. A digital education platform known as the "European Wellness Digital Education...
PR Newswire
22/06/2023

Hemophilia Market to Proliferate Immensly, Predicts DelveInsight | Key Companies…

Key Takeaways from the Hemophilia Market Report Key Takeaways from the Hemophilia Market Report Discover which therapies are expected to grab the major hemophilia market share @Hemophilia Market Report Hemophilia Overview Haemophilia is a genetic bleeding disorder that causes blood to clot improperly. This can cause spontaneous as well as post-injury or surgical bleeding. Blood contains several proteins known as clotting factors, which can help prevent bleeding. Patients...
PR Newswire
21/06/2023

Segway presents the Navimow with the innovation "VisionFence" at the spoga+gafa…

"With the rapidly expanding sales areas and growing sales volume, Navimow has become one of the best-known brands for robotic lawn mowers. Our goal is to provide the best mowing experience with the highest standards of product quality, customer service and channel support," said Ryan Kong, Head of Sales of Segway Navimow. "With the rapidly expanding sales areas and growing sales volume, Navimow has become one of the best-known brands for robotic lawn mowers. Our goal is to provide…
PR Newswire
21/06/2023

Therabody Named to TIME's List of The TIME100 Most Influential Companies

The TIME100 Most Influential Companies list is compiled through nominations from TIME's extensive network of contributors and experts, followed by rigorous evaluations on key factors such as impact, innovation, ambition, and success. The result is a diverse group of 100 businesses leading the way in charting a transformative path forward. Therabody's presence on this esteemed list further solidifies its position as the leader in wellness technology and proves the company's progress in providing…
PR Newswire
21/06/2023

Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox…

Mithra has access to the new EUR 12.5 million tranche of the Highbridge/Whitebox loan facilityLiege, Belgium ,21 June 2023 – 17:50 CEST– Mithra Pharmaceuticals SA (Euronext Brussels: MITRA) (the " Company " or " Mithra "), a company dedicated to Women's Health, today announces that it obtained access to a new tranche of the amended loan facility concluded with funds managed by Highbridge Capital Management, LLC (" Highbridge ") and funds managed by Whitebox…
Nasdaq GlobeNewswire
21/06/2023

Scivita Medical's 4K UHD Fluorescence Imaging System showcased at EAES 2023

Scivita Medical is a global medical technology company for minimally invasive diagnostics, establishing R&D centres in both China and Japan. Besides, Scivita Medical has obtained FDA-/CE- and PDMA-certifications for their products and applied patents in China as well as overseas. The company aims to increase market penetration with excellent products and be the preferred brand trusted by doctors and patients around the world through the continuous improvement of its core technologies…
PR Newswire
21/06/2023

  Valneva Announces Successful Outcome of its AGM and the Appointment of…

Saint-Herblain(France), June 21 , 2023–ValnevaSE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting (AGM) held today in Lyon, France. Among the adopted resolutions were approval of the 2022 financial statements, delegations for the management board to increase Valneva's share capital and/or issue financial...
Nasdaq GlobeNewswire
21/06/2023

NFL BIOSCIENCES: Approval for its patent to be granted on NFL-101 in Europe and…

NFL BIOSCIENCES: Approval for its patent to be granted on NFL-101 in Europe and approval of the clinical development plan for NFL-101 by the EMA NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is announcing that it has received approval from the European Patent Office for issuing its patent (17 716 853.1) for NFL-101, a nicotine-free botanical drug candidate comprising natural proteins...
Nasdaq GlobeNewswire
21/06/2023

Largest shareholder and Foundation to secure Coloplast future with new holding…

As part of a generational change, the largest shareholder in Coloplast A/S, Niels Peter Louis-Hansen, will establish a new holding company. The company will be co-founded with Coloplast's second-largest shareholder, the Aage & Johanne Louis-Hansen Foundation. The holding company will enable the stable and long-term development of Coloplast. The joint holding company will own approximately 30% of the company capital and have approximately 52% of the votes in Coloplast.”Coloplast has...
Nasdaq GlobeNewswire
21/06/2023

Vivoryon Therapeutics N.V. Reports Outcome of 2023 Annual General Meeting

Vivoryon Therapeutics N.V. Reports Outcome of 2023 Annual General MeetingAll proposed resolutions approvedElection oftwo new Non-Executive Board membersHalle (Saale) / Munich, Germany , June21 , 2023– Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a clinical stage company focused on the discovery and development of small molecule medicines to modulate the activity and stability of...
Nasdaq GlobeNewswire
21/06/2023

Casino Group: Update on the conciliation proceedings

Update on the conciliation proceedings Paris, 21 June 2023As part of the conciliation proceedings opened on May 25, 2023 in favor of Casino and some of its subsidiaries 1, Casino Group will use various levers to preserve its liquidity throughout the conciliation proceedings (lasting until 25 September, and extended, if necessary, until 25 October at the latest):- conclusion of an agreement in principle with the French government to defer payment of the Group's tax...
Nasdaq GlobeNewswire
21/06/2023

Dental 3D Printing Market worth $6.7 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258228239 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=258228239 Browse in-depth TOC on "Dental 3D Printing Market"250 - Tables40 - Figures250 - Pages Dental 3D Printing Market Scope: "During the forecast period, the materials segment is expected to be the fastest growing segment of the Dental 3D Printing market." Based on...
PR Newswire
21/06/2023

The futility analysis for IBT's Connection Study positive

“IBT announced earlier today that the Data Monitoring Committee (DMC) has performed the planned safety analysis of the study data of 1,403 babies. We have now also received results from the pre-planned futility analysis. It is therefore with great pleasure that I would like to convey that we are continuing with full steam ahead towards the goal of bringing IBP-9414 to the market”, stated CEO Staffan Strömberg.The positive outcome of the futility analysis indicates that there is a...
Nasdaq GlobeNewswire
21/06/2023

Dr. Yinfei Yin Joins Shanghai ChemPartner as Vice President and Head of Biology…

"Dr. Yin is an exceptional addition to our team, providing leadership and expertise to our biology and pharmacology efforts for drug discovery and development," said Lilly Xu, President of Shanghai ChemPartner. "His extensive research and leadership experience will greatly benefit ChemPartner and our global clients." "Dr. Yin is an exceptional addition to our team, providing leadership and expertise to our biology and pharmacology efforts for drug discovery and…
PR Newswire
21/06/2023

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities…

ORION CORPORATIONSTOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 21 JUNE 2023 at 17.00 EEST Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (KeskinäinenEläkevakuutusyhtiö Ilmarinen) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly or indirectly by Keskinäinen Eläkevakuutusyhtiö Ilmarinen increased on 21...
Nasdaq GlobeNewswire
21/06/2023

New research highlights a significant and continued gap in achieving diversity…

Preliminary results are to be presented during the Drug Information Association (DIA) 2023 Annual Global Meeting. The panel, including Otis Johnson, Clario Chief Diversity, Inclusion and Sustainability Officer, Ken Getz, Executive Director/Professor, Tufts CSDD, Karen Correa, Vice President, Head of Global Clinical Operations at Takeda, Alicia Rami, Associate Director Mobile Clinical Services, PMP, MBA, Fortrea and Todd Rudo, Chief Medical Officer, Clario, will preview the critical findings and…
PR Newswire
21/06/2023

Essity recognized as a sustainability leader

This year's index is based on the sustainability performance data derived from more than 62,000 companies assessed by EcoVadis between 2018 and 2022 across four themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. This year's index is based on the sustainability performance data derived from more than 62,000 companies assessed by EcoVadis between 2018 and 2022 across four themes: Environment, Labor & Human Rights, Ethics, and Sustainable Procurement. "As…
PR Newswire
21/06/2023

Amarin Announces Vascepa® (Icosapent Ethyl) Approved to Reduce Cardiovascular…

-- VASCEPA ®Approved in KSA To Reduce the Risk of Cardiovascular (CV) Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT-- -- VASCEPA Becomes First and Only Approved Medication in KSA for Reducing CV Risk Beyond Cholesterol Lowering Therapy in High-Risk Statin Treated Patients with Elevated and High Triglyceride Levels -- DUBLIN, Ireland and BRIDGEWATER, N.J., June...
Nasdaq GlobeNewswire
21/06/2023
Altri  Comunicati